BioFire Diagnostics
The Vice President of US Market Access is a strategic leadership role responsible for developing and executing the market access strategy for diagnostic products in the US, with a focus on payer engagement, coverage, reimbursement, and product adoption. The role involves cross-functional collaboration to optimize market access efforts and influence healthcare policies.
Headquarters
Salt Lake City, Utah, United States
Company Size
1001-5000 employees
Founded
1990
BioFire Diagnostics, now operating as a product franchise brand under bioMérieux, is the leader in syndromic infectious disease diagnostics. Its flagship BIOFIRE® FILMARRAY® System delivers rapid, multiplex PCR results in approximately one hour, with FDA-cleared panels covering respiratory, gastrointestinal, blood culture, meningitis/encephalitis, pneumonia, and joint infection pathogens. The BIOFIRE System is designed for minimal hands-on time and is widely used in hospitals and clinical labs to support faster diagnoses, antimicrobial stewardship, and infection control.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioFire Diagnostics.
Vice President, US Market Access
Deciphera Pharmaceuticals
Vice President, Market Access, HEOR and Patient Services - Radiopharma
lifelancer
Director of Market Access - VA and Government Specialist
CareDx, Inc.
Vice President, US Market Access
Alfasigma
Associate Director Access & Reimbursement
CSL
Director, Market Access Marketing
Sarepta Therapeutics